CCMI Jesús Usón

Trai
ning

1 CCMIJU offers advanced healthcare training tailored to the clinical and technological needs of 2026. The programs are designed to develop practical and strategic competencies in minimally invasive surgery, robotics, endoscopy, microsurgery, advanced therapies, and applied biotechnology. Each course combines specialized teaching, immersive simulation, and experience-based learning, ensuring solid, safe preparation focused on clinical practice. The faculty is composed of internationally renowned professionals who contribute scientific insight, technical rigor, and teaching experience in real healthcare environments.

Inves
tiga
tion

2 CCMIJU promotes biomedical innovation through national and international projects in translational medicine, minimally invasive surgery, and biomedical engineering. Its research activity integrates advanced technology, robotics, artificial intelligence, and bioengineering, with the aim of improving clinical-surgical procedures and developing solutions that transform medical practice.

Ser
vi
ces

3 The CCMIJU Quality Assurance and Regulatory Framework Unit ensures that preclinical studies comply with Good Laboratory Practice (GLP) and current regulatory standards. Its work encompasses the planning, execution, supervision, and reporting of studies, guaranteeing the integrity and reliability of results. In addition, it verifies product safety through standardized procedures in in vivo and in vitro studies, supporting researchers and study directors in regulatory compliance. CCMIJU holds ISO 9001 certification, endorsing its document management system and process management.

Trans
pa
rency

4 CCMIJU guarantees full transparency across all its processes, particularly in research and training. With an ethical approach, it facilitates access to the results of its preclinical studies, ensuring that both the scientific community and stakeholders can review the progress and methodology used. It also promotes accountability through clear and accessible reports, ensuring the reliability of its research. Collaboration with hospitals, clinics, and industry companies further fosters open communication and a continuous flow of information, strengthening trust in its innovative, high-quality work.

Nanbiosis

Nanbiosis proporciona soluciones integradas, a medida, para los desafíos que encuentran los investigadores en nanomedicina, diagnóstico médico, ingeniería de tejidos y dispositivos de medicina regenerativa.

CRO

Our CRO specialised in IN VIVO preclinical studies, offers customised solutions for both regulatory (GLP) and non-regulatory projects, attending to your needs, from pilot studies and proof of concept to regulated studies, minimising the risks prior to the clinical phase.